This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Merix, Keryx Biopharma: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.

Merix (MERX) jumped by 53 cents, or 22.8%, to $2.85 in the premarket session after the company late Monday reported fiscal second-quarter earnings of $500,000, or 2 cents a share, compared with a year-ago loss of $6.1 million, or 29 cents a share. Revenue fell to $71.3 million from $76.9 million in the year-ago period, although Merix said that despite seasonal factors, it has continued to see "very good bookings" during the month of December. The 50-day average daily volume for Merix is 107,000.

Keryx Biopharmaceuticals (KERX - Get Report) gained 22 cents, or 8.8%, to $2.73 in the premarket session after the company announced a special protocol assessment agreement with the Food and Drug administration for a Phase III registration program of Zerenex, its iron-based phosphate binder for the treatment for hyperphosphatemia in patients with end-stage renal disease (ESRD). The 50-day average daily volume for Keryx is 1.61 million shares.

Wave Systems (WAVX - Get Report) rose by 10 cents, or 6.3%, to $1.68 in the premarket session after the company said it received $5.7 million in software license and maintenance orders for a global automaker. The 50-day average daily volume for Wave Systems is 214,000 shares.

Zoom Technologies (ZOOM) jumped by 60 cents, or 9%, to $7.25 in the premarket session after Global Hunter Securities initiated coverage of the stock with a buy rating and a price target of $10. The firm said it expects continued growth ahead driven by strong domestic demand. The 50-day average daily volume for Zoom is 137,000 shares.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ZOOM $0.00 0.00%
KERX $5.26 3.54%
WAVX $0.02 -43.30%
AAPL $95.03 -2.90%
FB $116.73 7.20%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs